Commentary | Published:

Expanding rare disease drug trials based on shared molecular etiology

Nature Biotechnology volume 32, pages 515518 (2014) | Download Citation

Subjects

Current clinical trial approaches in rare disease test one drug on one indication defined by a clinical phenotype. For targeted drugs, grouping patients by molecular etiology would make much more sense.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    , , & Hum. Mutat. 29, 1037–1047 (2008).

  2. 2.

    , , & Annu. Rev. Med. 64, 407–425 (2013).

  3. 3.

    , , & Proc. Natl. Acad. Sci. USA 106, 3585–3590 (2009).

  4. 4.

    et al. PLoS Biol. 11, e1001593 (2013).

  5. 5.

    et al. Eur. Respir. J. 38, 59–69 (2011).

  6. 6.

    , , , & Proc. Natl. Acad. Sci. USA 110, 19483–19488 (2013).

  7. 7.

    et al. J. Exp. Med. 206, 2285–2297 (2009).

  8. 8.

    et al. J. Med. Chem. 52, 2836–2845 (2009).

  9. 9.

    N. Engl. J. Med. 363, 852–863 (2010).

  10. 10.

    & Trends Genet. 24, 552–563 (2008).

  11. 11.

    & Wiley Interdiscip. Rev. RNA 2, 837–852 (2011).

  12. 12.

    & Trends Mol. Med. 12, 306–316 (2006).

  13. 13.

    et al. PLoS ONE 8, e60478 (2013).

  14. 14.

    & Cold Spring Harb. Perspect. Biol. 3, a004507 (2011).

  15. 15.

    & Curr. Pharm. Des. 19, 3497–3508 (2013).

  16. 16.

    EMBO Mol. Med. 1, 268–279 (2009).

  17. 17.

    & Chem. Biol. 19, 315–327 (2012).

  18. 18.

    , , & Science 319, 916–919 (2008).

  19. 19.

    , , & J. Biol. Chem. 286, 43454–43464 (2011).

  20. 20.

    et al. Proc. Natl. Acad. Sci. USA 111, 249–254 (2014).

  21. 21.

    , & PLoS Biol. 6, e26 (2008).

  22. 22.

    Nat. Biotechnol. 31, 189 (2013).

  23. 23.

    , & Arch. Bronconeumol. 50, 146–150 (2014).

  24. 24.

    Hum. Mutat. 9, 195–208 (1997).

  25. 25.

    , , & Hum. Mutat. 29, 567–583 (2008).

  26. 26.

    et al. Lancet Oncol. 14, 472–480 (2013).

  27. 27.

    et al. Mol. Ther. 19, 830–840 (2011).

  28. 28.

    & Discov. Med. 16, 233–239 (2013).

  29. 29.

    , & Am. J. Med. Genet. C. Semin. Med. Genet. 157, 63–71 (2011).

  30. 30.

    & Am. J. Hum. Genet. 82, 539–566 (2008).

  31. 31.

    et al. J. Biol. Chem. 287, 39349–39360 (2012).

  32. 32.

    & Biochem. Biophys. Res. Commun. 336, 150–156 (2005).

  33. 33.

    et al. Pediatr. Res. 70, 480–483 (2011).

  34. 34.

    et al. J. Mol. Med. (Berl.) 85, 149–161 (2007).

  35. 35.

    & Nat. Rev. Genet. 8, 749–761 (2007).

  36. 36.

    et al. Hum. Mutat. 33, 530–540 (2012).

  37. 37.

    Nat. Chem. Biol. 3, 533–535 (2007).

  38. 38.

    & Nat. Rev. Drug Discov. 7, 854–868 (2008).

  39. 39.

    , & Front. Mol. Neurosci. 4, 24 (2011).

  40. 40.

    et al. Ann. Neurol. 69, 940–953 (2011).

  41. 41.

    , , & J. Mol. Cell Biol. 5, 214–226 (2013).

  42. 42.

    & Expert Opin. Pharmacother. 5, 2255–2262 (2004).

  43. 43.

    et al. Pediatr. Res. 64, 213–217 (2008).

  44. 44.

    et al. Sci. Transl. Med. 3, 80ps16 (2011).

Download references

Acknowledgements

P.J.B. is also a Program Director in the Division of Metabolism and Health Effects, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland, USA.

Author information

Affiliations

  1. Philip J. Brooks and Steve Groft are at the Office of Rare Diseases Research, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, Bethesda, Maryland, USA.

    • Philip J Brooks
    •  & Steve Groft
  2. Danilo A. Tagle is at the Office of Special Initiatives, Office of the Director, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, Bethesda, Maryland, USA.

    • Danilo A Tagle

Authors

  1. Search for Philip J Brooks in:

  2. Search for Danilo A Tagle in:

  3. Search for Steve Groft in:

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Philip J Brooks.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nbt.2924

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing